Effect of Transdermal Magnesium and Moderate Intensity TheraBand Training on Pressure, Pain Threshold, Disability and Quality of Life Among Adults with Sciatic Pain: A Randomized Controlled Trial

Introduction: Sciatic pain, commonly known as sciatica, is a prevalent condition characterized by radiating pain along the sciatic nerve pathway, significantly affecting an individual’s quality of life due to discomfort, numbness, and muscle weakness.

Aim: To study the effect of transdermal magnesium and moderate intensity TheraBand training on quality of life among adults with sciatic pain. Cost-effective, non-invasive methods of treating sciatic pain are becoming more and more necessary. Investigating the synergistic effects of transdermal magnesium and moderate-intensity TheraBand training may provide an innovative approach to promote integrative pain management techniques by enhancing quality of life, lowering disability, and improving pressure pain threshold in impacted individuals.

Material and Methods: A two-group pretest-post-test randomised clinical trial will be conducted in recognised hospitals in Delhi using simple random sampling from February 2025 to February 2026. Two groups will be formed, each consisting of 56 subjects. Group A will serve as the experimental group receive a transdermal magnesium spray and TheraBand exercises. Group B, the control group, will receive sham transdermal magnesium spray and TheraBand exercises, both groups will be treated for 3 days in a week for 8 weeks. The paired t-test will be employed to assess subjective parameters within the same group, while the unpaired t-test will be used for intergroup comparisons, establishing a significance level of <0.05. This integrated approach addresses both biochemical and functional aspects, offering comprehensive rehabilitation benefits.